About 22 million Americans would face sharply higher healthcare costs if enhanced ACA tax credits expire at the end of the ...

The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...

Function Health raised a $298 million Series B round, pushing its valuation into unicorn territory at $2.5 billion. The ...

Johnson & Johnson is adding to its oncology pipeline with a $3.05 billion deal to acquire Halda Therapeutics, a startup whose first-in-class approach to prostate cancer could overcome drug resistance ...

Oral Genome, a leader in saliva-based oral health testing, has been honored with the 2025 Cellerant Best of Class Hygiene Award, recognizing the company’s innovative contribution to preventive oral ...